Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Heidi Oster

Obstetrics & Gynecology Lone Tree, CO Medical Doctor

NPI 1902863541 CMS profile 1129358

10099 Ridge Gate Parkway, Suite 280, Lone Tree, CO 80124

Open in the dashboard

General payments

$7,871

226 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Heidi Oster of Lone Tree, CO is reported in the CMS Open Payments database as having received $7,871 across 226 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $929 35
2024 General $1,165 35
2023 General $996 35
2022 General $3,260 52
2021 General $834 38
2020 General $324 18
2019 General $363 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Heidi Oster
  • Obstetrics & Gynecology median
  • Middle half of Obstetrics & Gynecology
  • National median

In program year 2025, general payments to Heidi Oster were reported at $929. Among 21,306 Obstetrics & Gynecology profiles paid that year, the median was $158 and the middle half received between $51 and $401.

Show as a table
Year Heidi Oster Obstetrics & Gynecology median Middle half National median
2019 $363 $172 $62–$391 $163
2020 $324 $94 $36–$222 $114
2021 $834 $136 $42–$369 $132
2022 $3,260 $160 $50–$433 $149
2023 $996 $169 $56–$423 $160
2024 $1,165 $152 $50–$371 $164
2025 $929 $158 $51–$401 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $2,395 4 payments
  2. AbbVie, Inc. $1,029 51 payments
  3. Hologic, LLC $993 25 payments
  4. Organon LLC $374 18 payments
  5. CooperSurgical, Inc. $273 13 payments
  6. Mayne Pharma Inc. $268 9 payments
  7. Bayer HealthCare Pharmaceuticals Inc. $240 12 payments
  8. Exeltis, USA Inc. $223 10 payments
  9. Astellas Pharma US Inc $210 6 payments
  10. Coloplast Corp $161 2 payments
  11. Other $1,706 76 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,372 222 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,250 2 payments
  3. Consulting Fee $150 1 payment
  4. Education $99 1 payment
Products named General payments · program years 2019–2025
  1. DA VINCI SP $2,250 2 payments
  2. ACESSA PROVU SYSTEM $606 13 payments
  3. LO LOESTRIN FE $434 21 payments
  4. NEXPLANON $278 14 payments
  5. Mirena $240 12 payments
  6. Kyleena $240 12 payments
  7. NOVASURE $235 4 payments
  8. MYOSURE TISSUE REMOVAL DEVICE $194 3 payments
  9. LILETTA $190 12 payments
  10. ORIAHNN $166 5 payments
  11. Other $3,605 165 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

461

Median for Obstetrics & Gynecology: 65

Drug cost

$30,696

Median for Obstetrics & Gynecology: $3,585

Branded share of claims

58.8%

Median for Obstetrics & Gynecology: 25.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Estradiol (Twice Weekly) Estradiol Brand 83 $9,528
Estring Estradiol Brand 12 $6,513
Progesterone Progesterone, Micronized Brand 101 $4,296
Dotti Estradiol Brand 31 $4,239
Estradiol Generic 78 $3,866
Synthroid Levothyroxine Sodium Brand 19 $976
Levothyroxine Sodium Generic 98 $916
Nitrofurantoin Nitrofurantoin Macrocrystal Brand 13 $187
Acyclovir Generic 14 $163
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 12 $13

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 24,311 Part D prescribers listed as Obstetrics & Gynecology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 29 billing codes

Paid by Medicare

$29,551

Medicare's payments for the services billed

Medicare patients

155

Average age 70

Services billed

573

155 women, 0 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 49%
High blood pressure 43%
Depression 17%
Osteoporosis 17%
Cancer 15%
Chronic kidney disease 12%
Diabetes 10%
Ischemic heart disease 10%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 8 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
UNITHROID
  • Amneal Pharmaceuticals LLC $64
$64 — —
Veozah
  • Astellas Pharma US Inc $44
$44 — —
MYFEMBREE
  • Sumitomo Pharma America, Inc. $20
$20 — —
QUVIVIQ
  • IDORSIA PHARMACEUTICALS US INC $16
$16 — —
SLYND
  • Exeltis, USA Inc. $15
$15 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 8 in the dashboard with a free account

Records

226 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Obstetrics & Gynecology in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record